Patents by Inventor Lorna Ehrlich

Lorna Ehrlich has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Assay for TSG101 as inhibitors of HIV production
    Patent number: 7494767
    Abstract: The present invention provides methods for identifying peptides in a mammalian. Tsg101 protein that binds to the PTAPP (SEQ ID NO: 3) motif or L domain of human immunodeficiency virus type I (HIV-1). Such peptides can be used to inhibit Tsg101-HIV Gag binding, and is therefore effective in reducing HIV particle production. The invention also provides the peptides identified by the method of the invention and to method of using such peptides for treating HIV infection.
    Type: Grant
    Filed: May 21, 2002
    Date of Patent: February 24, 2009
    Assignee: Functional Genetics, Inc.
    Inventors: Carol Carter, Arthur Goff, Lorna Ehrlich, Stanley N. Cohen
  • Tsg101 as inhibitors of hiv production
    Publication number: 20050287525
    Abstract: The present invention provides methods for identifying peptides in a mammalian. Tsg101 protein that binds to the PTAPP motif or L domain of human immunodeficiency virus type I (HIV-1). Such peptides can be used to inhibit Tsg101-HIV Gag binding, and is therefore effective in reducing HIV particle production. The invention also provides the peptides identified by the method of the invention and to method of using such peptides for treating HIV infection.
    Type: Application
    Filed: May 21, 2002
    Publication date: December 29, 2005
    Inventors: Carol Carter, Arthur Goff, Lorna Ehrlich, Stanley Cohen
  • TSG101 as inhibitor of HIV production
    Publication number: 20050009745
    Abstract: The present invention provides methods for identifying peptides in a mammalian. Tsg101 protein that binds to the PTAPP motif or L domain of human immunodeficiency virus type I (HIV-1). Such peptides can be used to inhibit Tsg101-HIV Gag binding, and is therefore effective in reducing HIV particle production. The invention also provides the peptides identified by the method of the invention and to method of using such peptides for treating HIV infection.
    Type: Application
    Filed: September 18, 2003
    Publication date: January 13, 2005
    Inventors: Carol Carter, Arthur Goff, Lorna Ehrlich, Stanley Cohen